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Abstract
Background: Tinnitus is a common chronic health condition that affects 10% to 20% of the
general population. Among severe sufferers it causes disability in various areas. As a result of the
tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective
treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive
multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to
examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by
a specialized tinnitus center versus usual care. This paper describes the study protocol.
Methods/Design: In a randomized controlled clinical trial 198 tinnitus patients will be randomly
assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred
to the audiological centre are eligible. Included patients will be followed for 12 months. Primary
outcome measure is generic quality of life (measured with the Health Utilities Index Mark III).
Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific
fear, and costs. Based on health state utility outcome data the number of patients to include is 198.
Economic evaluation will be performed from a societal perspective.
Discussion: This is, to our knowledge, the first randomized controlled trial that evaluates a
comprehensive treatment of tinnitus and includes a full economic evaluation from a societal
perspective. If this intervention proves to be effective and cost-effective, implementation of this
intervention is considered and anticipated.
Trial Registration: The trial has been registered at ClinicalTrial.gov. The trial registration
number is NCT00733044
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Problem definition
The disease
Subjective tinnitus is the involuntary perception of the
concept of a sound without the presence of an external
source. It is a chronic condition that is highly prevalent,
especially among hearing impaired individuals. Studies
show a prevalence of 10% to 20% in the general popula-
tion [1,2] and among hearing impaired individuals prev-
alence has been estimated at 75% to 80% [3]. Of the
Dutch population at least 2 million individuals suffer
from some form of tinnitus, 340.000 individuals indicate
to hear the tinnitus continuously and 60.000 individuals
claim to be severely impaired in their daily activities [4].
Among severe sufferers it causes disability associated with
severe affective problems, major declines in concentra-
tion, sleeping difficulties, hypersensitivity to sounds and
problems in (re-)directing attention. The combination of
these complaints makes them feel exhausted and frus-
trated resulting in diminished quality of life [5-9]. Tinni-
tus is known to occur as a concomitant of almost all the
dysfunctions that involve the human auditory system [1],
and it is postulated that the aetiology of tinnitus is diverse
and that different activation circumstances can be present
[10]. Little is known about the pathophysiology and there
is no known drug or curative therapy at present [11]
though considerable research effort has been expended in
this regard.
The health care problem
In many cases tinnitus sufferers are referred to different
caregivers in a non-standardized way, and often receive
insufficient and sometimes inappropriate treatment. This
may comprise prescribing a drug that is not proven to be
effective, or informing the patients that not much can be
done to improve the situation. Especially in those individ-
uals suffering from a moderate to severe tinnitus, incorrect
information and delay of appropriate treatment is
expected to increase psychological strain, aggravation of
tinnitus severity, and prolongation of the referral trajec-
tory [11]. Since tinnitus sufferers seek help in various
areas of health care without receiving appropriate treat-
ment, they are financially burdening the system superflu-
ously. In absence of a proven cure or uniformly effective
treatment, tinnitus care is often fragmentised and costly
[12].
Usual Care
As for most health problems in the Dutch population, the
general practitioner (GP) is the initial professional to con-
sult for patients with tinnitus. In most cases, within six
months after onset of subjective tinnitus the individual
consults his GP, but one quarter of the respondents wait
several years until they seek help [4]. In the official Dutch
GP patient information letter on tinnitus (URL: http://
www.nhg.artsennet.nl), it is stated that there is not much
that can be done to alleviate complaints. Another fre-
quently consulted specialist is the ENT physician. Treat-
ment possibilities include removal of cerumen,
medication, and audiological rehabilitation. Generally,
the effects of these treatments are disappointing.
Motivation and relevance for the chosen intervention
A recent study by El Refaie et al (2004) shows that func-
tional and social handicap in tinnitus sufferers is signifi-
cantly reduced, and quality of life improves significantly,
as a result of attendance at a specialised tinnitus clinic.
Specialised clinics for chronic disorders such as tinnitus
and chronic pain have been proven to be most effective in
treatment [13]. Similarities between tinnitus and chronic
pain in terms of cognitive and behavioural mechanisms
[14] have been suggested recently and a similar treatment
could be effective for the tinnitus population. As in
chronic pain, multidisciplinary specialised treatment is
more effective in ameliorating severe tinnitus complaints
than monodisciplinary treatments. A retrospective pilot
study, by the applicants of this proposal, in the Tinnitus
Centre Limburg (TCL) shows significant improvements in
71% of the patients (N = 41). Intrusiveness of the tinnitus
ameliorates in 85% of the subjects and 78% experiences
improvement in emotional distress caused by the tinnitus.
Objective
The objective of this study is to examine the effectiveness,
costs and cost-effectiveness of a comprehensive multidis-
ciplinary treatment provided by a specialised tinnitus cen-
tre. Treatment is based on a stepped care approach,
tailored to individual needs, with key elements from cog-
nitive behavioural therapy, education, relaxation tech-
niques, attention diversion, exposure in daily live
situations, and tinnitus retraining therapy.
The following research questions were formulated:
1. What are the effects on generic quality of life of compre-
hensive specialized tinnitus care as provided by a special-
ised tinnitus centre, as compared to usual care?
2. What are the effects on health, in terms of negative
affect, tinnitus beliefs, fear of the tinnitus, and tinnitus
annoyance, of comprehensive specialized tinnitus care as
provided by a specialised tinnitus centre, as compared to
usual care?
3. What are the costs to health care and to society of treat-
ment provided by a specialised tinnitus centre in the
Dutch health care system as compared to usual care?Page 2 of 8
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a specialised tinnitus centre in the Dutch health care sys-
tem as compared to usual care?
Methods/design
Design
A randomised controlled clinical trial will be performed,
with 2 conditions (Fig. 1). Patients will be assigned to a
Usual Care (UC) Control condition or a Tinnitus Centre
Limburg care (TCL) condition. Both treatment conditions
(UC and TCL) will be provided by the Audiological Centre
Hoensbroeck. Measures will be taken for blinding patients
to treatment assignment.
For assessing the cost-effectiveness, the TCL care group
will be compared only to the UC group and not to other
treatment programs. The analysis will be performed from
a societal perspective.
Participants
The study population consists of tinnitus sufferers referred
to the TCL, with subjective tinnitus complaints, aged 18
years and older. Exclusion criterion is not being able to
write and read in Dutch.
Inclusion of patients started on September 1st 2007 and
will proceed until the targeted number of patients is
reached, for a maximum of 18 months. It is expected that
enough patients will be referred to the TCL during this
period to reach the necessary number as was calculated by
power-analysis.
Sample size calculation and feasibility of recruitment
After attending a specialised tinnitus clinic a change of
0.065 in health state utility as measured with the SF-6D
has been observed [9]. To detect this difference (assuming
a two-sided significance level = 0.05, power = 80%, stand-
ard deviation of the difference = 0.15), 86 persons per
Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburgigure 1
Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburg.
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up, the required sample size is 99 persons per group (198
persons in total).
Approximately 400 individuals suffering from tinnitus
apply to TCL yearly. We expect this number to stay stable
or even increase in the coming years. Therefore it is
expected that it will not be necessary to actively recruit
patients for this trial.
Patient allocation and randomization
Research information in written format and a declaration
of willingness to participate in the trial will be sent to all
new patients of the Tinnitus Centre Limburg that are reg-
istered with subjective tinnitus complaints. If a patient
declares that he or she is willing to participate in the study
they will be invited for the baseline measurement. This
face-to-face contact will be used to determine whether the
patients understood the information correctly and a writ-
ten informed consent will be obtained. If they agree, a
hearing test will be performed to determine the level of
hearing loss and the patients are asked to fill in the tinni-
tus questionnaire (TQ) [15] to determine the severity of
the tinnitus. Based on the Fletcher Index and the scores on
the TQ the patient will be randomly assigned to one of the
treatment groups. Since treatment depends on tinnitus
severity and the severity of hearing loss it will be impor-
tant that these two prognostic factors are equally pre-
sented in the UC group and the TCL group.
Treatment allocation will be achieved by block randomi-
sation (four blocks; A, B, C & D) to ensure equal and bal-
anced groups. A randomization list was generated using
randomization software. An equal number of patients will
be allocated to the TCL group and the UC group. Patients
with a score equal to or less than 46 on the TQ and a
Fletcher Index below 60 dB will be allocated to block A.
Patients with a score equal too or less than 46 on the TQ
and a Fletcher Index equal to or above 60 dB will be allo-
cated to block B. Patients with a score above 46 on the TQ
and a Fletcher Index below 60 dB will be allocated to
block C. Finally, patients with a score equal to or below 46
on the TQ and a Fletcher Index above or equal to 60 dB
will be allocated to block D. The randomization proce-
dure will be performed by an independent person at a
location outside TCL.
Intervention
The intervention consists of comprehensive tinnitus man-
agement provided by a specialized tinnitus centre in the
health care system. The tinnitus centre offers care follow-
ing a stepped-care approach with two levels (see Fig. 1).
Stepped care is a framework for organizing health services
based on patients' needs, with a gradual increase in the
intensity of the care at each level [16].
The first level of intervention consists of a basic multidis-
ciplinary intervention for all patients referred to TCL. This
multidisciplinary intervention consists of audiological
diagnostics (Table 1) and intervention, a tinnitus educa-
tional group session and an individual consult with a clin-
ical psychologist. For patients with mild complaints this
basic multidisciplinary intervention is expected to suffice.
For patients with moderate to severe complaints a second
level of intervention exists. This second level of interven-
tion consists of combinations of the following therapies:
Cognitive Behavioural Therapy (CBT), Attention Diver-
sion (AD) by means of movement therapy to build up a
more positive mind-body relationship, exposure tech-
niques, and Relaxation Therapy (RT). The programs are
preferably offered in group format. The group treatments
are based on the theoretical framework of the fear-avoid-
ance model proposed by Lethem and colleagues [17],
refined by Vlaeyen and Linton [18], and a cognitive
behavioural model by Kröner-Herwig [8] explaining fac-
tors in the development and maintenance of chronic tin-
nitus. Based on existing knowledge in chronic pain
management, Folmer et al [14] formulated treatment
strategies possibly effective for patients suffering from
chronic tinnitus, or as they put it, chronic phantom
"pain". The authors conclude that severity of depression,
anxiety and insomnia is highly correlated with the severity
of the tinnitus, similar to chronic pain. They suggest that
techniques and strategies effective in treating chronic pain
disorder, might be useful in treating tinnitus as well. These
include: stress management techniques (including relaxa-
tion therapy) to reduce physiological reactivity, cognitive-
behavioural techniques to reduce catastrophising cogni-
tions and reduce avoidance behaviours and exposure to
fear-eliciting stimuli to adjust for estimations of the tinni-
tus sound. The treatment under investigation consists of
three main programs namely; program A for patients suf-
fering from tinnitus on a moderate to severe level, pro-
gram B for severe tinnitus complaints, and program C for
the severely hearing impaired suffering from tinnitus. All
programs are based on the principals stated above.
Depending on severity of complaints and hearing loss,
group treatment is more intense and tailored to individual
needs. In a review from Andersson and Lyttkens [19] it
Table 1: Audiological diagnostics and intervention in first level
Audiological diagnostics and intervention
1. Pure tone and speech audiometry
2. Uncomfortable Loudness Level measurement
3. Tympanometry: including stapedial reflexes
4. Hearing aid check and optimisation (if present)
5. Tinnitus analyses: Pitch Mask Frequency and Masking level
6. Tinnitus anamnesis using structured questionnaire
7. Individual consult by clinical physicist in audiology (60 minutes)Page 4 of 8
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techniques in combination with relaxation exercises
received the most empirical support.
Usual Care
Usual care consists of a standardized version of the treat-
ment that is currently applied in peripheral audiological
centres throughout the Netherlands for tinnitus patients.
A telephone survey was conducted amongst all audiolog-
ical centres (n = 28) in the Netherlands. The results of this
survey determined the content of the usual care treatment
protocol in the current study. The treatment consists of
audiological diagnostics and intervention and, if neces-
sary, one or more consultations with a social worker with
a maximum of ten one hour sessions.
Outcomes and instruments
Primary outcome measure:
· Generic quality of life, as measured with the Health Util-
ities Index Mark 3 (HUI3) [20]
Secondary outcome measures:
· Anxiety and depression as measured with the Hospital
Anxiety and depression Scale (HADS) [21];
· Tinnitus related disability and handicap, as measured
with the Tinnitus Handicap Inventory (THI) [22];
· Tinnitus annoyance and severity, as measured with the
Tinnitus Questionnaire (TQ) [15];
· Tinnitus-related fear was assessed by the Fear of Tinnitus
Questionnaire (FTQ). This novel 17-item questionnaire is
based on the Tampa scale for Kinesiophobia [23] and the
Pain Anxiety Symptoms Scale [24];
· Dysfunctional beliefs and/or cognitions regarding the
tinnitus, as measured with the Tinnitus Coping and Cog-
nition list (TCCL). The TCCL is a recent adaptation of the
Pain Coping and Cognition Questionnaire [25];
· Catastrophic (mis)interpretations of tinnitus, as meas-
ured with the Tinnitus Catastrophising Scale (TCS). The
TCS is a recent adaptation of the Pain Catastrophising
Questionnaire [26];
· Costs, as measured with a retrospective cost question-
naire.
Data collection
Measurement of the HUI3, TQ, THI, HADS, FTQ, TCCL,
TCS and a cost questionnaire will take place at four
moments during a 12 month period. At baseline (T0) the
questionnaires will be completed at the audiological cen-
tre in the presence of a research assistant. Three (T1), eight
(T2) and twelve (T3) months after baseline the patient
will be able to complete the questionnaires at home
through the internet. Login codes will be sent to their
home address two weeks in advance. If patients are inca-
pable of completing the questionnaire through the inter-
net, a paper version will be provided. Non-responders will
receive a telephone call as a reminder to complete the
questionnaires. If they do not wish to further participate
in the study, the reasons for their withdrawal will be
recorded.
Data-analysis
Intention-to-treat analysis will be performed, including
all patients that were originally enrolled in the study, irre-
spective of whether they completed the therapy. To test
the differences between the conditions, mixed multilevel
regression analyses will be used with a hierarchical back-
ward elimination method. The analysis will be carried out
for the POST treatment assessments (after level 1 and level
2 respectively) and follow-up data of the outcome varia-
bles. The independent variables are: PRE measurements of
the dependent variable, treatment condition, treatment
centre, sociodemographics, tinnitus-related variables, and
the interaction variable PRE-measurement*treatment.
The treatment condition always remains in the regression
model, but the other independent variables will be added
to increase the power of the analysis and are subsequently
eliminated to keep only the significant ones. At each step
of the analysis, tests will be done to check for high co-lin-
earity (VIF>10) and/or outliers (Cook's Distance (Cook
D)) and Studentised Residual (Sresid)). If Cook D > 1 the
case will be removed from the analysis. If Sresid < -3 or >
3, the case will be removed providing that Cook D of this
case is considerably higher than from the other cases. By
looking at plots of the relationship between each inde-
pendent variable and the dependent variable, a possible
curvilinear relationship is excluded. The prediction errors
will be also checked for normality (zresid). For each
dependent variable, the initial regression model includes
all independent variables and interaction mentioned
above. Non-significant interactions (p > .05) will be
deleted from the model. Next, non-significant (p > .10,
two-tailed) predictors will be deleted one by one, except
the treatment factor that always remains in the model. If a
significant interaction is found, the treatment effect will
be evaluated within strata defined by the covariate inter-
acting with the treatment.
Based on the results of the intention-to-treat analysis,
additional per protocol analysis will be performed, incor-
porating only those patients that completed the therapy.
The same analyses as according to the intention-to-treatPage 5 of 8
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outcomes.
Economic Evaluation
A cost-effectiveness analysis will be performed from a
societal perspective. Since both effects on costs and
generic health-related quality of life are to be expected, the
method of economic evaluation is a cost-utility analysis.
The primary effect parameter is generic health-related
quality of life, measured in quality adjusted life years
(QALYs). The time horizon of the study is one year, iden-
tical to the duration of the follow up in the clinical study.
The immediate treatment effects (measurements at 3 and
6 months) and short-term treatment effects (measure-
ment at 12 months) are observed in this study. It is not
possible to observe long-term treatment effects (longer
than12 months), since the duration of the study is limited
to three years. Discounting is not relevant given the one-
year time horizon. Sampling uncertainty surrounding the
incremental cost-utility ratio will be estimated by non-
parametric bootstrapping. Confidence intervals for the
incremental cost-utility ratio will be calculated from the
bootstrap results. The implications of sampling uncer-
tainty on decision uncertainty (the probability specialised
tinnitus care provided in a specialised tinnitus centre is
more cost-effective than usual care) will be quantified
using the cost-effectiveness acceptability curve. Sensitivity
analyses will be used to show the impact of variation in
non-stochastic input parameters on the incremental cost-
utility ratio, such as discount rate, unit prices, and design
issues. The impact of variability on the incremental cost-
utility ratio arising from diversity and heterogeneity in the
patient population will be examined in subgroup analy-
ses. Costs in the analysis include direct health care costs
(medical costs for prevention, diagnostics, therapy, reha-
bilitation and care), direct non-health care costs (travel
costs) and indirect costs (productivity loss). Resource use
will be measured using the case-record forms and 3
monthly retrospective cost-questionnaires. In the cost
questionnaires the PRODISQ modules will be used to
estimate productivity loss [27]. When available, the stand-
ard unit costs from the Dutch Manual for Cost Analysis
[28] will be used. Resource use for which no standard unit
costs are available will be valued using integral cost calcu-
lations. Costs from productivity loss will be quantified
using the friction cost method, as recommended in the
Netherlands [28].
Ethical considerations
Patients will be informed verbally and in written format
about the research project before they sign the informed
consent form. Participants can retreat from the study at
any moment. This will have no influence on their further
treatment.
The study protocol has been reviewed and approved by
the Medical Ethical Board of the Rehabilitation Founda-
tion Limburg.
The scientific merits of the study protocol have been
reviewed in the consecutive phases of research funding
process by the independent reviewers of the funding
organization ZonMw, the Netherlands Organization for
Health Research and Development.
Funding
A grant was obtained in a competitive application process
of the efficacy research program, round 2006, of the Neth-
erlands Organization for Health and Development
ZonMw.
Discussion
Potential strengths of the study protocol
Design
To our knowledge this is the first randomized controlled
clinical trial that evaluates a comprehensive multidiscipli-
nary treatment of tinnitus versus care as usual. A particular
strength is the randomization procedure, in which alloca-
tion is concealed. Randomization is done at the patient
level and stratified on degree of hearing impairment and
tinnitus severity. This procedure is performed by an exter-
nal independent person.
Sample size
To our knowledge this is the first study evaluating a com-
prehensive multidisciplinary treatment of tinnitus that
includes a large sample size. At least 198 patients with tin-
nitus will be included in the study. As a result most statis-
tical procedures will be robust against violations of
assumptions that have to do with normality.
Recruitment strategy
In this randomized controlled trial every recruited patient
experiences tinnitus to be one in three of their major com-
plaints. Since tinnitus does not have to be the primary
problem it is ascertained that different severity levels of
tinnitus will be evaluated in this study.
Competence of health care professionals
Every discipline is trained to perform the intervention in a
uniform way. To get insight into their actual performance,
every professional is required to register all activities dur-
ing all treatment-related activities during patient visits.
This registration will be used to search for factors related
to the intervention that might influence effectiveness.
Potential limitations of the study protocol
Intervention
There is no uniform way of treating tinnitus in the audio-
logical centres in the Netherlands. In order to model usualPage 6 of 8
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amongst all audiological centres. This implicates that the
currently implemented form of usual care is standardized,
whereas in real practice clinical variation in treatment is
expected.
Randomization approach
Randomization on patient level could lead to contamina-
tion, and bias the results of this study. However, the influ-
ence of contamination is minimised since patients in the
usual care group have no access to the intervention offered
by TCL-specialists and vice versa. Nevertheless it is possi-
ble that specialists that provide the usual care treatment,
are more attentive to the usual care group than would be
expected if treatment was provided in an independent
centre. As a result our findings may be conservative.
Conclusion
This study will provide information on whether a compre-
hensive, multidisciplinary treatment is more effective and
efficient care for tinnitus patients. The results will also
show whether the specialised treatment improves quality
of life and patient satisfaction. If the intervention is
proven to be effective, implementation of the intervention
is considered and anticipated. First results are not
expected before the beginning of 2010.
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